• Home
• Partneringtools
• Reports

• In-licensing
• Out-licensing
• Companies

• Articles
• Events
• Outsourcing

• Consulting
• Jobs
• Forums

• About us
• Products
• Newsletter

Pharmalicensing Ltd
is a division of

News of the day

Industry news search

Recent news

To keep up to date with news from this category use our

KANE BIOTECH RECEIVES NOTICE OF ALLOWANCE FOR DispersinB(TM) AS A REGISTERED TRADEMARK
WINNIPEG, Manitoba (June 25, 2008) - Kane Biotech Inc. (TSX-V: KNE), a biotechnology company engaged in the development of products that prevent and disperse microbial biofilms, is pleased to announce that the Company...

Pathway Medical Technologies Awarded New Patent for Pathway PV(TM) Atherectomy System for Improved Differential Cutting
Kirkland, WA, June 25, 2008--Pathway Medical Technologies, Inc., an innovator of endovascular treatments for peripheral arterial disease (PAD), announced it was recently granted another patent for its Pathway PV(TM)...

HepaLife(TM) Develops New Liver Stem Cell Lines for Bioartificial Liver Device; Data Presented at Scientific Conferences
Boston, MA - June 25, 2008 - HepaLife Technologies, Inc. (OTCBB: HPLF) (FWB: HL1) (WKN: 500625), today announced the development of two new derivative cell lines from the Company's patented PICM-19 liver stem cells for...

GTC BIOTHERAPEUTICS LICENSES RECOMBINANT FIBRINOGEN PATENTS TO PHARMING
FRAMINGHAM, MA - June 25, 2008 -- GTC Biotherapeutics, Inc. ("GTC", Nasdaq: GTCB) announced today that it has granted an exclusive license for recombinant fibrinogen in Europe, North America, and Japan to Pharming Group...

INTRADIGM ANNOUNCES ALLOWANCE OF KEY RNA INTERFERENCE (RNAi) PATENT
Palo Alto, CA, June 17, 2008 - Intradigm Corporation, a leading developer of targeted, systemic RNA interference (RNAi) therapeutics, today announced that the United States Patent and Trademark Office (USPTO) has...

Cephalon Announces Issuance of Patent for AMRIX
FRAZER, Pa., June 17 -- Cephalon, Inc. (Nasdaq: CEPH) announced today that the U.S. Patent and Trademark Office has issued a pharmaceutical formulation patent for AMRIX(R) (Cyclobenzaprine Hydrochloride Extended-Release...

Given Imaging Announces Completion of Patent Litigation Settlement
YOQNEAM, ISRAEL, June 17, 2008 -- Given Imaging Ltd. (NASDAQ: GIVN) (TELAVIV: GIVN) announced today that it has signed the final settlement agreement with Olympus Corporation ending the patent litigation between the...

Results of Zolpidem study
June 17, 2008 -- ReGen Therapeutics Plc ('ReGen' or the 'Company') announces that collaborators at Aston University, Birmingham UK have significantly clarified the basis of zolpidem's beneficial effects in brain injured...

Vical Pandemic Influenza Vaccines Provide Complete Protection in Animal Studies; The Journal of Infectious Diseases Publishes H5N1 Challenge Data
SAN DIEGO, June 16, 2008 -- Vical Incorporated (Nasdaq: VICL) announced today the publication of results demonstrating that pandemic influenza DNA vaccines formulated with the company's patented Vaxfectin(R) adjuvant...

PTO Extends Reexamination of Tessera Patent
SAN JOSE, Calif. -- June 16, 2008 -- Tessera Technologies, Inc. (Nasdaq:TSRA), a leading provider of miniaturization technologies for the electronics industry, today announced the U.S. Patent and Trade Office (PTO) late...

Probiodrug Obtains Core Patent in the U.S.
Halle/Saale, June 16, 2008 -- Probiodrug AG (Probiodrug), a developer of small molecule inhibitors for the treatment of inflammatory and neurodegenerative diseases, announced today that the United States Patent Office...

Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio
TUSTIN, Calif., June 16, 2008 -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical stage biopharmaceutical company developing monoclonal antibodies for the treatment of cancer and hepatitis C virus infection...

Teva Announces Tentative Approval of Generic Diovan® Tablets
Jerusalem, Israel, June 12, 2008 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted tentative approval for the Company's Abbreviated New Drug...

InNexus Biotechnology Announces Expansion of Patent Protection of DXL(TM) Technology -- Company Receives Allowance of Patent Claims from both US and European Patent Offices
BRITISH COLUMBIA, Canada - 12 June 2008 - InNexus Biotechnology Inc. (OTCBB: IXSBF)(TSX VENTURE: IXS), (http://www.ixsbio.com), a drug development company commercializing the next generation of monoclonal antibodies...

Greatbatch Announces Issuance of Key MRI Patent
CLARENCE, N.Y.-- June 12, 2008--Greatbatch, Inc. (NYSE: GB) announced today that the U.S. Patent and Trademark Office has issued the Company patent 7,363,090. The patent provides Greatbatch with the exclusive right to...

GPC Biotech Announces Granting of European Patent Related to Satraplatin for Treating Tumors Resistant or Refractory to Taxanes
Martinsried/Munich (Germany) and Princeton, N.J., June 12, 2008 - GPC Biotech AG (Frankfurt Stock Exchange: GPC; NASDAQ: GPCB) today announced the granting of a European Patent (EP 1 720 540 B1) related to satraplatin,...

Allowance of US Patent on Isobaric Tandem Mass Tags & TMT® Launch at ASMS
12th June 2008 -- COBHAM, England - Proteome Sciences plc ("Proteome Sciences") is pleased to announce that the USPTO has issued a Notice of Allowance for its US patent application in isobaric mass labelling for its...

QIAGEN Files Appeal in Patent Case
Gaithersburg, Maryland, June 11, 2008 - QIAGEN Gaithersburg, Inc. (formerly Digene Corporation), a wholly-owned subsidiary of QIAGEN N.V. (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA), today announced that it has filed...

Genentech Settles Dispute Related To Cabilly Patent
South San Francisco, Calif. -- June 11, 2008 -- Genentech, Inc. (NYSE: DNA) announced today that it has settled its patent litigation with MedImmune, Inc. involving the Cabilly patent (U.S. Patent No. 6,331,415), which...

Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement with Johns Hopkins University
St. Louis - June 11, 2008 - Orion Genomics announced today that the company entered into a worldwide exclusive license agreement with The Johns Hopkins University (JHU) to commercialize products that identify patients...

KV Pharmaceutical Company Comments on Legal Development in its Branded Pharmaceutical Business
St. Louis, MO, June 10, 2008 - KV Pharmaceutical Company (NYSE: KVa/KVb), a fully integrated specialty pharmaceutical company that develops, manufactures, acquires and markets technology-differentiated branded products...

Lifeline Biotechnologies, Inc. Prepares Patent Filing for Improved First Warning(TM) Diagnostic System
Reno, NV - June 10, 2008 - Lifeline Biotechnologies, Inc. (OTCPK: LLBT) , a developer of innovative medical technology, today announced that it has begun preparation of a provisional patent on a new neural network...

Genta Receives Notice of Allowances for European Patents Related to Composition and Processes for Tesetaxel, a Leading Oral Taxane
BERKELEY HEIGHTS, NJ - June 10, 2008 - Genta Incorporated (OTCBB: GNTA) announced that the Company has received notice of allowances for two major patents from the European Patent Office for its pipeline product,...

Provectus Pharmaceuticals Receives US Patent Providing Further Protection for Novel Agent PH-12
June 10, 2008 -- KNOXVILLE, Tenn -- Provectus Pharmaceuticals, Inc. (OTCBB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, has received its third US patent protecting...

Mylan Wins Generic Prilosec® Patent Litigation
PITTSBURGH, June 10, 2008 -- Mylan Inc. (NYSE: MYL) announced today that the U.S. Court of Appeals for the Federal Circuit has affirmed a May 2007 District Court ruling stating that Mylan's 10 mg and 20 mg Omeprazole...

METABOLON AWARDED ADDITIONAL METABOLOMICS PATENT
RESEARCH TRIANGLE PARK, NC (June 10, 2008)--Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, announced today that the company has been awarded another metabolomics patent. The newly...

Barr Confirms Patent Challenge of Prevacid(R) SoluTab(TM) Delayed-Release Orally Disintegrating Tablets, 15mg and 30mg
MONTVALE, N.J., June 10 -- Barr Pharmaceuticals, Inc. (NYSE: BRL) today confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by TAP Pharmaceuticals Inc. in connection...

TELIK ANNOUNCES PATENTS ON COMPOUNDS RELATED TO TELINTRA
Palo Alto, CA, June 10, 2008- Telik, Inc. (Nasdaq: TELK), announced today that the European Patent Office has issued notices of allowance for two applications covering new compounds related to one of Telik's lead...

Lescarden Announces its First Order from the Philippines for Poly-NAG(R)
June 09, 2008 -- NEW YORK-- Lescarden Inc. (LCAR.OB), a marketing and R&D company based in New York, today announced that it has received its first order for Poly-NAG® from Pascual Laboratories Inc., one of the largest...

Four Independent Research Groups Present Data Generated by Pressure Cycling Technology (PCT) at the ASMS Conference on Mass Spectrometry and Allied Topics in Denver, CO
SOUTH EASTON, Mass., June 9, 2008 -- Pressure BioSciences, Inc. (Nasdaq: PBIO; "PBI") today announced that scientists from Pacific Northwest National Laboratories (PNNL), the Harvard School of Public Health (HSPH), the...

Hanmi to roll out its generic Lipitor next year
June 09, 2008 -- Hanmi plans to roll out its improved generic version of Lipitor next year as it almost finished its clinical trials.

Oriel Therapeutics, Inc. - receives 4th US Patent
Research Triangle Park, NC, June 9, 2008-- Oriel Therapeutics today announced that the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent Number 7,377,277, issue date May 27, 2008, for dry powder dose...

StemCells, Inc.'s New Patent Strengthens Its Leadership in the Discovery and Use of Monoclonal Antibodies for Isolating Rare Cells
PALO ALTO, Calif. June 6, 2008 - StemCells, Inc. (NASDAQ: STEM) today announced that the U.S. Patent and Trademark Office has issued Patent Number 7,381,561 claiming the use of additional monoclonal antibodies for the...

Javelin Pharmaceuticals, Inc. Announces New Patent Covering PMI-150 (Intranasal Ketamine)
CAMBRIDGE, Mass., June 04, 2008 -- Javelin Pharmaceuticals, Inc. (Amex: JAV), a leading developer of specialty prescription medications for pain management was today granted a commercially important patent in the...

Antares Pharma, Inc. (ANTR) Receives a Notice of Allowance for U.S. Patent Covering Anturol(TM)
EWING, N.J.--June 04, 2008-Antares Pharma, Inc. (AMEX:AIS) a specialty pharmaceutical company, today reported that the United States Patent & Trademark Office (USPTO) has issued a Notice of Allowance for U. S. patent...

OXFORD GENE TECHNOLOGY FILES SUIT AGAINST BIOARRAY SOLUTIONS
Oxford, UK - June 04, 2008 - Oxford Gene Technology (OGT) announces on 28th May 2008 the Company filed suit against Bioarray Solutions Ltd of Warren, NJ for infringement of OGT's patent numbers US 6,307,039, US...

Mylan Confirms Patent Challenge Relating to Azor®
PITTSBURGH, June 4, 2008 -- Mylan Inc. (NYSE: MYL) today confirmed that its majority-owned subsidiary, Matrix Laboratories Ltd., has been sued by Daiichi Sankyo in connection with Amlodipine Besylate/Olmesartan...

Oculus Innovative Sciences Files for Patent Protection on Breakthrough Wound Care Device to Accelerate Wound Healing
PETALUMA, Calif., Jun 04, 2008 -- Oculus Innovative Sciences, Inc. (Nasdaq: OCLS), a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform,...

VNUS Announces Settlement of Patent Litigation with AngioDynamics and Vascular Solutions
SAN JOSE, Calif., June 3, 2008 -- VNUS® Medical Technologies, Inc. (Nasdaq: VNUS) today announced that it has entered into an Agreement with AngioDynamics (Nasdaq: ANGO) and Vascular Solutions (Nasdaq: VASC) that...

Aphios Corporation Awarded Japanese Patent for Phospholipid Nanosomes Technology Platform
May 29, 2008 -- Aphios Corporation today announced that it has been awarded a Japanese Patent No. 4,107,680, issued on April 11, 2008, for its phospholipid nanosomes technology platform for the encapsulation of...

NUVO LICENSES TOPICAL PAIN PRODUCT FROM PALADIN
Mississauga, Ontario, Canada - May 29, 2008 - Nuvo Research Inc. (TSX: NRI), a Canadian drug development company focused on the research and development of drug products delivered to and through the skin using its...

FULL FEDERAL COURT AFFIRMS THE AUSTRALIAN FEDERAL COURT'S DECISION IN FAVOR OF RANBAXY ON PFIZER'S ATORVASTATIN PATENT ON APPEAL
Gurgaon, Haryana, India, May 28, 2008 -- Ranbaxy Laboratories Limited announced that the Federal Court of Australia-Full Court today upheld the favorable decision rendered earlier by the Federal court in the company's...

US MICRONEEDLE PATENT GRANTED
May 21, 2008 -- Medical technologies group Norwood Abbey Ltd confirms that the US Patent office has advised it has granted an additional patent to the Massachusetts Institute of Technology ('MIT'), flowing from Norwood...

Corning Awarded Additional Patent for Label-free Drug Development Technology
CORNING, N.Y., May 21, 2008 - Corning Incorporated (NYSE:GLW) today announced that the United States Patent and Trademark Office issued the company an additional patent related to the Corning® Epic® System that deals...

U.S. Patent Office Allows Another Significant VNUS Patent
SAN JOSE, Calif., May 9, 2008 -- VNUS® Medical Technologies, Inc. today announced that the U.S. Patent & Trademark Office has decided to allow a second continuation patent application related to the patents in the VNUS...

Pathway Diagnostics Announces Commercial Availability of Second Generation SensiTrop(TM) II Molecular HIV Co-receptor Tropism Assay
Malibu, California, May 7, 2008 - Pathway Diagnostics announces nationwide availability of its patented second generation molecular SensiTrop(TM) II assay, combining the sensitivity of molecular heteroduplex tracking...

Regulus Therapeutics Exclusively Licenses Intellectual Property from Stanford University Relating to microRNA Antagonists to Treat Inflammatory Diseases
CAMBRIDGE, Mass. & CARLSBAD, Calif. - May 6, 2008 - Regulus Therapeutics LLC, a joint venture between Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) formed to discover,...

NUCLEA BIOMARKERS ANNOUNCES THAT IT HAS RECEIVED A U.S. PATENT ON "KINASE PEPTIDES AND ANTIBODIES"
Pittsfield, Massachusetts ....April 10,2008.... Nuclea Biomarkers, LLC announced today that it has been accorded U.S. Patent No. 7,354,725 B2 entitled "Kinase Peptides and Antibodies," which issued on April 8,2008. "The...

Antares Pharma, Inc. (ANTR) Receives a Notice of Allowance for U.S. Patent Covering Anturol(TM)
EWING, N.J.--April 06, 2008--Antares Pharma, Inc. (AMEX:AIS) a specialty pharmaceutical company, today reported that the United States Patent & Trademark Office (USPTO) has issued a Notice of Allowance for U. S. patent...

New patent granted - Micromuscle's patent "Microtools" has been granted in USA several EU countries
January 08, 2008 -- New patent granted - Micromuscle's patent "Microtools" has been granted in USA several EU countries. The Microtools patent covers the use of electroactive components and devices, e.g. in surgical...

New patent has been granted in Japan
November 26, 2007 -- New patent has been granted in Japan. The patent is based on differential adhesion and covers manufacturing methods for microstructures used in the production of electroactive polymer actuators.

New patent granted - The patent "Method for Producing a Micromachined Layered Device" has been granted in US and validated in several EU countries
November 21, 2007 -- New patent granted - The patent "Method for Producing a Micromachined Layered Device" has been granted in US and validated in several EU countries. The patent covers generic manufacturing methods...

NEEDLEFREE INJECTION PATENT GRANTED
September 12, 2007 -- Medical technologies group Norwood Abbey Ltd [ASX:NAL] advises that the Australian Commissioner of Patents has granted an additional patent to the Massachusetts Institute of Technology ('MIT'),...

NEEDLE-FREE INJECTION PATENT GRANTED
April 30, 2007 -- Medical technologies group Norwood Abbey Ltd [ASX:NAL] advises that the Australian Commissioner of Patents has granted an additional patent flowing from its research at the Massachusetts Institute of...

MICRONEEDLE PATENT GRANTED
March 05, 2007 -- Medical technologies group Norwood Abbey Ltd [ASX:NAL] advises that the Australian Commissioner of Patents has granted an additional patent to the Massachusetts Institute of Technology ('MIT'), flowing...

SpectraScience receives second Patent notification
February 27, 2007 -- San Diego, CA SpectraScience, Inc. (SCIE.OB) announced today that it has received the official decision for the grant of another European Patent number 1063921 for its "Optical Biopsy Forceps System...

ADDITIONAL EPI-LASIK PATENT GRANTED IN US
January 16, 2007 - Medical technologies group Norwood Abbey Ltd [ASX:NAL] advises that the US Patent Office has granted an additional patent of the Norwood EyeCare patent portfolio, relating to Epi-LASIK refractive...

MIT Patent Granted in Australia
Jan 15, 2007 -- Medical technologies group Norwood Abbey Ltd [ASX:NAL] advises that its Research Partner Massachusetts Institute of Technology has been granted Patent Number 2002353840 by the Australian Patents Office....

SpectraScience receives Patent notification
January 12, 2007 -- San Diego, CA SpectraScience, Inc. (SCIE.OB) announced today that it has received them official decision to grant a European Patent number 0910284 for its Optical Biopsy Forceps design.

SpectraScience files new patent application
November 9, 2006 -- San Diego, CA SpectraScience, Inc. (SCIE.OB) announced today that it has filed for a new patent with the United States Patent and Trademark Office.

PBI Technology, Inc. Signs License Agreement for SalivaSac® with Evergreen Innovation Partners
Seattle, Washington, May 4, 2006 - PBI Technology, Inc. (PBI Tech), a wholly owned subsidiary of Pacific Biometrics, Inc. (OTC BB: PBME), has entered into a Patent and Know-how License Agreement with Evergreen...

Patent for the plasmid, the producer strain and the method of producing of recombinant human interferon alfa-2b is issued to Pharmapark LLC.
December 2004 --Patent for the plasmid, the producer strain and the method of producing of recombinant human interferon alfa-2b is issued to Pharmapark LLC.

Patent application for pharmaceutical composition of the injectable form of recombinant human interferon alfa-2b is submitted.
July 2004 --Patent application for pharmaceutical composition of the injectable form of recombinant human interferon alfa-2b is submitted.

Industry news: Pharmalicensing provides comprehensive industry coverage.

Products:	Partnering Consulting	Partnering Search	Company Profiling	Comparision	Partneringtools	Reports
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Outsourcing
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search	Add your event
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic	Post your article
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Company releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us